[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366888-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366888-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-imaging-in-early-skin-cancer-detection-advances-limitations-and-future-directions","Molecular Imaging in Early Skin Cancer Detection - Advances, Limitations, and Future Directions","","Early detection of skin cancer is essential for effective treatment and improved patient outcomes. Advances in oncologic molecular imaging enable visualization of tumors and cellular processes at the molecular level, supporting identification of early-stage cancers that may be missed by conventional imaging. Modalities such as reflectance confocal microscopy and optical coherence tomography, alongside skin fluorescent imaging targeting αvβ3 integrin, offer non-invasive options. Integrating in vivo molecular imaging with tumor biomarkers supports more precise diagnosis, prognosis, and personalized treatment monitoring.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-imaging-in-early-skin-cancer-detection-advances-limitations-and-future-directions/366888/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-imaging-in-early-skin-cancer-detection-advances-limitations-and-future-directions/366888.png","ImageObject",300,407,{"name":42,"@type":43},"LangkahRina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is early skin cancer detection important?","Question",{"text":63,"@type":64},"Early detection enables less aggressive treatment, preserves healthy tissue, improves quality of life, lowers costs, and reduces mortality through timely intervention.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is molecular imaging used for in early-stage skin cancer?",{"text":68,"@type":64},"Molecular imaging supports in vivo visualization of tumor heterogeneity, angiogenesis, and treatment monitoring by targeting proteins, receptors, and metabolic processes, enabling non-invasive identification of molecular changes.",{"name":70,"@type":61,"acceptedAnswer":71},"What challenges limit molecular imaging technologies in oncology?",{"text":72,"@type":64},"Key challenges include spatial limitations, interpretative variability, and concerns about cost and accessibility, especially compared with more widely available options like ultrasound and optical imaging.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366888,1790557586,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893776,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Molecular Imaging in Early Skin Cancer Detection: Advances, Limitations, and Future Directions  \nTechnology in Cancer Research & Treatment  \nVolume 24: 1-11 © The Author(s) 2025 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/15330338251410073](DOI: 10.1177/15330338251410073)[ ](DOI: 10.1177/15330338251410073)[journals.sagepub.com/home/tct](journals.sagepub.com/home/tct)  \nElizabeth Berry, MD 1 , Reid F. Thompson, MD, PhD2 , Catherine Shachaf, PhD3  , and Sancy Leachman, MD, PhD4  \nAbstract  \nEarly detection of skin cancer is crucial for effective treatment and improved patient outcomes. Recent advancements in oncologic imaging, particularly molecular imaging techniques, have revolutionized cancer diagnostics and treatment by enabling the visualization of tumors and cellular activities at the molecular level. These techniques facilitate the identiﬁcation of early-stage cancers that might remain undetectable through traditional imaging methods. Innovative technologies such as reﬂectance confocal microscopy (RCM) and optical coherence tomography (OCT) which visualize skin at near-histologic detail and skin ﬂuorescent imaging (SFI), which targets αvβ3 integrin expression, are promising for non-invasive early detection of melanoma. By integrating in vivo molecular imaging with tumor biomarkers, clinicians can gain more precise insights into processes integral to cancer biology, leading to improved diagnosis, prognosis and the development of personalized treatment strategies. This  \nreview explores imaging modalities used in skin cancer diagnosis, highlighting their advantages and limitations, with an emphasis on molecular imaging, stressing its potential to improve early detection, personalize treatment and monitor therapeutic responses.  \nKeywords  \nReview, stroma, tumor microenvironment, biomarker, melanoma, nevus, tissue remodeling, in vivo imaging, αvβ3 integrin, SFI  \nReceived: 30 July 2025; revised: 6 November 2025; accepted: 26 November 2025  \nIntroduction  \nEarly cancer detection is crucial. It enables less aggressive treatment, preserves healthy tissue, improves quality of life, lowers costs and reduces mortality through timely intervention.1 Compared with standard biopsy and histology, imaging is less invasive and more effective for tumor analysis, offering a comprehensive, dynamic view of the tumor and its microenvironment rather than a static snapshot.  \nOver the past century, medical imaging has evolved dramatically; from the early use of x-rays for basic structural visualization, to the development of computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET), which have allowed increasingly detailed insights into both anatomy and function. Today, the ﬁeld is entering a new era of precision, where imaging is no longer limited to structure or metabolism and can extend into molecular characterization of disease. Emerging modalities and hybrid  \nplatforms now offer the ability to visualize speciﬁc molecular targets, cellular processes and dynamic interactions within the stromal tumor microenvironment (STE) . This convergence of imaging and biomarker science holds transformative potential for early diagnosis, therapeutic monitoring and personalized  \n1 Department of Dermatology, Oregon Health & Science University, Portland, OR, USA  \n2Department of Radiation Medicine, Oregon Health & Science University, Portland, OR, USA; Division of Hospital and Specialty Medicine, VA Portland Healthcare System, Portland, OR, USA  \n3Orlucent Inc., Los Gatos, CA, USA  \n4Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA  \nCorresponding Author:  \nCatherine Shachaf, Orlucent Inc., 61 E Main St, Los Gatos, CA, USA.  \nEmail: [cshachaf@orlucent.com](cshachaf@orlucent.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of t","cbCainsUa12dsagg","https://ap.wps.com/l/cbCainsUa12dsagg","pdf",876499,11,"English","# Abstract\n# Introduction\n## Role of early cancer detection\n## Evolution of medical imaging and shift toward molecular characterization\n## Molecular imaging concepts and promise\n## Limitations and challenges","[{\"question\":\"Why is early skin cancer detection important?\",\"answer\":\"Early detection enables less aggressive treatment, preserves healthy tissue, improves quality of life, lowers costs, and reduces mortality through timely intervention.\"},{\"question\":\"What is molecular imaging used for in early-stage skin cancer?\",\"answer\":\"Molecular imaging supports in vivo visualization of tumor heterogeneity, angiogenesis, and treatment monitoring by targeting proteins, receptors, and metabolic processes, enabling non-invasive identification of molecular changes.\"},{\"question\":\"What challenges limit molecular imaging technologies in oncology?\",\"answer\":\"Key challenges include spatial limitations, interpretative variability, and concerns about cost and accessibility, especially compared with more widely available options like ultrasound and optical imaging.\"}]","Molecular Imaging in Early Skin Cancer Detection - Advances, Limitations, and Future Directions | PDF",1790168127,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27139ea6af47a15dc643abe6388ac86a.webp",983,1276,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4286763aacfc578fa2e084747c8d46da.webp",982,1275,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cccff6bc5c717d38b6ba78a9c5648666.webp",981,1273,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9a4235119dff56c252a10cfcfe649239.webp",980,1272]